Skip to content

Clinical trials

Acute Coronary Syndrome trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Country / region: Italy Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20052
20064
20075
20083
20099
201011
20115
20127
201310
20149
20153
20166
20176
20185
20195
20204
202110
20224
20237
20247
20257
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66
Unknown status35
Recruiting17
Terminated6
Not yet recruiting5
Active, not recruiting3
Enrolling by invitation2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Federico II University10
A.O.U. Città della Salute e della Scienza7
Heart Care Foundation6
AstraZeneca5
Fondazione Policlinico Universitario Agostino Gemelli IRCCS4
University Hospital of Ferrara4
University of Bologna4
Bristol-Myers Squibb3
Centro Cardiopatici Toscani3
GlaxoSmithKline3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome136
Coronary Artery Disease28
Myocardial Infarction23
ST Elevation Myocardial Infarction19
Angina, Unstable14
Non-ST Elevated Myocardial Infarction14
Myocardial Ischemia10
Cardiovascular Diseases9
Coronary Disease9
Heart Diseases7

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.